Clarithromycin-Induced Long QT Syndrome: A Case Report

dc.contributor.authorCetin, M
dc.contributor.authorYildirimer, M
dc.contributor.authorÖzen, S
dc.contributor.authorTanriverdi, S
dc.contributor.authorCoskun, S
dc.date.accessioned2025-04-10T10:32:05Z
dc.date.available2025-04-10T10:32:05Z
dc.description.abstractLong QT syndrome develops for a number of reasons. The number of non-antiarrhythmic drugs reported to induce QT interval prolongation with or without torsade de pointes continues to increase. Clarithromycin is a macrolide antibiotic being increasingly used for the treatment of atypical pneumonia. In this paper, we describe a patient who developed long QT prolongation syndrome after receiving clarithromycin for the treatment of atypical pneumonia.
dc.identifier.e-issn1687-9635
dc.identifier.issn1687-9627
dc.identifier.urihttp://hdl.handle.net/20.500.14701/38507
dc.language.isoEnglish
dc.titleClarithromycin-Induced Long QT Syndrome: A Case Report
dc.typeArticle

Files